EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 / No 3 (Mars 2007) Med Sci (Paris), 23 3 (2007) 323-326 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Number 3, Mars 2007
Page(s) 323 - 326
Section Repères
DOI https://doi.org/10.1051/medsci/2007233323
Published online 15 March 2007
  1. Foucault M. Dits et écrits 1954-1988. Paris: Gallimard, 1994 : 4744 p. [Google Scholar]
  2. Clarke AE, Mamo L, Fisman JR, et al. Biomedicalization: technoscientific transformations of health, illness, and US biomedicine. Am Sociol Rev 2003; 68 : 161–94. [Google Scholar]
  3. Marshall E. Fast technology drives new world of newborn screening. Science 2001; 294 : 2272–4. [Google Scholar]
  4. Lindee S. Babies’blood. Phenylketonuria and the rise of public health genetics. In: Moments of truth in genetic medicine. Baltimore: Johns Hopkins University Press, 2005 : 28–57. [Google Scholar]
  5. ACMG. Newborn screening: toward a uniform screening panel and system. Report of the American College of Medical Genetics, 2005. [Google Scholar]
  6. Profiling the newborn: a prospective gene technology ? Report from a Joint working group of the Human genetics commission and the UK National screening committee, 2005. [Google Scholar]
  7. Collectif. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. Proceedings of a 1997 workshop. MMWR Recomm Rep 1997; 46 : 1–24. [Google Scholar]
  8. Grosse SD, Boyle CA, Botkin JR, et al. Newborn screening for cystic fibrosis. Evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep 2004; 53 : 1–36. [Google Scholar]
  9. Wilfond BS, Parad RB, Fost N. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. J Pediatr 2005; 147 : S109–13. [Google Scholar]
  10. Vailly J. Une politique de santé a priori : le dépistage néonatal de la mucoviscidose en Bretagne. Sci Soc Sante 2004; 22 : 35–60. [Google Scholar]
  11. Conrad P, Gabe J. Sociological perspectives on the new genetics: an overview. Sociol Health Illn 1999; 21 : 505–16. [Google Scholar]
  12. Wilson J, Jungner G. Principles and practice of screening for disease. Public Health Papers World Health Organization. 1968. [Google Scholar]
  13. ONM. Rapport sur la situation de la mucoviscidose en 1999. Paris : Observatoire national de la mucoviscidose (Institut national d’études démographiques, Vaincre la mucoviscidose), 2001. [Google Scholar]
  14. Fassin D, Memmi D. Le gouvernement des corps. Paris : Éditions de l’École des hautes études en sciences sociales, 2004 : 270 p. [Google Scholar]
  15. Marks H. La médecine des preuves. Histoire et anthropologie des essais cliniques. Le Plessis-Robinson: Institut Synthélabo (1re édition anglaise, 1997), 1999 : 352 p. [Google Scholar]
  16. Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med 1997; 337 : 963–9. [Google Scholar]
  17. Farrell P, Li Z, Kosorok M, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Resp Crit Care Med 2003; 168 : 1100–8. [Google Scholar]
  18. Vailly J. Genetic screening as a technique of government: the case of neonatal screening for cystic fibrosis in France. Soc Sci Med 2006; 63 : 3092–101. [Google Scholar]
  19. Fassin D. Entre politiques du vivant et politiques de la vie : pour une anthropologie de la santé. Anthropol Soc 2000; 24 : 95–116. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.